Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database - Zhao, Shuai; Wang, Yan; Deng, Xiaoli; Chen, Xi; Lu, Zhaoyi (Scientific reports, 2025)
Keywords: 631/67; 692/499; 692/700; Adverse Drug Reaction Reporting Systems - statistics & numerical data; Adverse drug reactions (ADRs); Adverse events; Adverse events (AEs); Algorithms; Antineoplastic Agents, Immunological - adverse effects; Bayes Theorem; Bayesian analysis; Cetuximab; Cetuximab - adverse effects; Databases, Factual; Discitis; Disseminated intravascular coagulation; Drug metabolism; Drug-Related Side Effects and Adverse Reactions - epidemiology; Female; Glomerulonephritis; Head and neck cancer; Humanities and Social Sciences; Humans; Lymphatic system; Male; Metastases; Monoclonal antibodies; multidisciplinary; Neoplasms - drug therapy; Neural networks; Nutrition; Nutrition disorders; Patient safety; Preferred terms (PTs); Retrospective Studies; Science; Science (multidisciplinary); Side effects; System organ class (SOC); Targeted cancer therapy; United States; United States Food and Drug Administration; United States; Head and neck cancer; Adverse events (AEs); System organ class (SOC); Preferred terms (PTs); Cetuximab; Adverse drug reactions (ADRs)